The levels of CD4+ T-cells infiltrating the tumor were low and no different than levels observed in the control for mice immunized with CDC25B or COX2 peptides (p>0.55 for both; Figure 5C and Supplementary Figure 4). This evidence concerns the gene CD4 and neoplasm.